4//SEC Filing
Nolan Garry Ph.D. 4
Accession 0001104659-22-099627
CIK 0001711933other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 4:07 PM ET
Size
7.1 KB
Accession
0001104659-22-099627
Insider Transaction Report
Form 4
Nolan Garry Ph.D.
Director
Transactions
- Sale
Common Stock
2022-09-12$13.30/sh−1,800$23,944→ 631,093 total - Sale
Common Stock
2022-09-09$13.31/sh−22,191$295,338→ 632,893 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.36, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001857405
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 4:07 PM ET
- Size
- 7.1 KB